Clinical trial · Observational
Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases
Factors Influencing the Impact of Contrast-Enhanced Intraoperative Ultrasound During Liver Surgery for Colorectal Cancer Liver Metastases
NCT01526200CI-TRIAL-00006187CEIOUSCLMcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Contrast-enhanced intraoperative ultrasound (CE-IOUS) during surgery for colorectal liver metastases (CLM) has become a part of clinical practice. However, if it should be selectively or routinely applied remains unclear. This study is carried out to clarify which are the criteria for a selective use of CE-IOUS if any.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer Liver Metastasis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Contrast-enhanced intraoperative ultrasound | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- CEIOUS
- description
- One hundred and twenty-seven consecutive patients -77 males and 50 females, mean age of patients was 61 years (median 65 years; range 29-85 years)- underwent liver resection using intraoperative ultrasound and contrast-enhanced intraoperative ultrasound.
- interventionNames
- Procedure: Contrast-enhanced intraoperative ultrasound
Primary outcomes (1)
- measure
- new colorectal liver metastases detected at contrast-enhanced intraoperative ultrasonography
- timeFrame
- October 2007 - March 2011 (up to 4 years)
Secondary outcomes (2)
- measure
- new colorectal liver metastases detected at intraoperative ultrasonography
- timeFrame
- October 2007 - March 2011 (up to 4 years)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 29 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * consecutively enrolled patients with CLM who underwent surgery and during this procedure received IOUS and CE-IOUS. * each patient had at least 6 months of postoperative follow-up. Exclusion Criteria: * patients who after IOUS and CE-IOUS had explorative laparotomy only were excluded from the analysis since there was no histological confirmation of the tumor and most of them were lost to surgical follow-up
References
Publications (0)
Data not yet available
No reference posted for this study.